Metraipolis › archive › dc_cf47ca3eca86

UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma — Europe PMC PMID:40861472

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40861472
DOI: 10.3389/fimmu.2025.1636503
License (as archived): solo-consultazione
Archived: 2026-11-10T18:09:36.904Z
SHA-256 of the archived text: 7f6b20844d62e2c7f966690d0c0e05f017271eb8dc3afdedf66f25fcf4a7bc1a
Stable URL of this page: https://metraipolis.com/documento/dc_cf47ca3eca86

How to cite

UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma — Europe PMC PMID:40861472 — Europe PMC (en), https://europepmc.org/article/MED/40861472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf47ca3eca86 (Metraipolis archive dc_cf47ca3eca86, sha256 7f6b20844d62e2c7f966690d0c0e05f017271eb8dc3afdedf66f25fcf4a7bc1a)

BibTeX

@misc{dccf47ca3eca86,
  title = {UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma — Europe PMC PMID:40861472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40861472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf47ca3eca86; sha256 7f6b20844d62e2c7f966690d0c0e05f017271eb8dc3afdedf66f25fcf4a7bc1a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40861472. Agents can read the archived copy with the MCP tool read_document.